| Literature DB >> 32731900 |
Tejs Ehlers Klug1, Thomas Greve2, Malene Hentze3.
Abstract
BACKGROUND: The vast majority of patients with peritonsillar abscess (PTA) recover uneventfully on abscess drainage and antibiotic therapy. However, occasionally patient´s condition deteriorates as the infection spread in the upper airway mucosa, through cervical tissues, or hematogenously. The bacterial etiology of PTA is unclarified and the preferred antimicrobial regimen remains controversial. The current narrative review was carried out with an aim to (1) describe the spectrum of complications previously recognized in patients with peritonsillar abscess (PTA), (2) describe the bacterial findings in PTA-associated complications, and (3) describe the time relation between PTA and complications.Entities:
Keywords: Bacteria; Complications; Microbiology; Peritonsillar abscess
Year: 2020 PMID: 32731900 PMCID: PMC7391705 DOI: 10.1186/s12941-020-00375-x
Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN: 1476-0711 Impact factor: 3.944
Fig. 1PRISMA flow diagram of the literature searches
Overview of complications to peritonsillar abscesses (PTA)
| Mechanism of propagation and complication | No. of patients | Malesa | Age, median years (range) | Time relation between PTA and complication (time of diagnosis) | Acute tonsillitis prior to PTAa | Antibiotic treatment prior to complicationa | Mortalitya | Sequelaea | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PTA prior | Same time | PTA after | Unknown | ||||||||
| Upper airway spread | |||||||||||
| Airway obstruction | 14 | 62% | 17 (0–68) | 1 | 12 | 0 | 1 | 58% | 88% | 7% | 0% |
| Epiglottitis | 15 | 100% | 41 (27–64) | 0 | 5 | 0 | 10 | 80% | 80% | 0% | – |
| Neck tissue spread | |||||||||||
| Para- and retropharyngeal abscess | 96 | 77%b | 62c (14–75) | 2 | 8 | 0 | 86 | 0%d | 50% | 0% | 0% |
| Necrotizing fasciitis | 38 | 76%e | 51 (20–87) | 17 | 6 | 0 | 15 | 22% | 89% | 21% | 46% |
| Mediastinitis | 113 | 65%f | 52 (15–82) | 13 | 13 | 0 | 87 | 41% | 74% | 19% | 38% |
| Internal carotid artery lesion | 7 | 57% | 15 (3–95) | 2 | 5 | 0 | 0 | 33% | 50% | 0% | 50% |
| Parotid gland abscess | 1 | 0% | 60 | 0 | 1 | 0 | 0 | – | 100% | 0% | 0% |
| Mastricator space abscess | 2 | 50% | 83 (75–90) | 2 | 0 | 0 | 0 | 0% | 100% | 0% | – |
| Hematogenous spread | |||||||||||
| Lemierre´s syndrome | 35 | 52% | 21 (0–65) | 2 | 21 | 3 | 9 | 40% | 27% | 10% | 50% |
| Sepsis | 2 | 50% | 10 (0–20) | 0 | 0 | 2 | 0 | 50% | 100% | 0% | 0% |
| Lung infections | 2 | 100% | 38 (14–61) | 1 | 0 | 1 | 0 | 50% | 100% | 0% | 0% |
| Carditis | 3 | 100% | 52 (17–80) | 2 | 0 | 1 | 0 | 50% | 50% | 67% | – |
| Brain abscess | 1 | 0% | 9 | 0 | 1 | 0 | 0 | 100% | 0% | 0% | 100% |
| Septic arthritis | 1 | 100% | 55 | 0 | 1 | 0 | 0 | 100% | 100% | 0% | 100% |
| Immunologic reaction | |||||||||||
| Reactive arthritis | 1 | 0% | 32 | 1 | 0 | 0 | 0 | 100% | 100% | 0% | 0% |
| STSS | 1 | 100% | 68 | 0 | 1 | 0 | 0 | 0% | 0% | 0% | 0% |
| Unknown | |||||||||||
| Kawasakis syndrome | 2 | 100% | 7 (7–7) | 2 | 0 | 0 | 0 | 100% | 100% | 0% | 0% |
| All | 334 | 70%2 | 41 (0-95) | 45 | 74 | 7 | 208 | 42% | 69% | 10% | 21% |
PTA peritonsillar abscess. STSS Streptococcal toxic shock syndrome
aPercentage of cases with information provided (gender: n = 235; acute tonsillitis prior to PTA: n = 98; antibiotic treatment prior to complication: n = 156; mortality: n = 273; sequelae: n = 87)
bp < 0.001, binomial probability test
cn = 5
dn = 4
ep = 0.003, binomial probability test
fp = 0.04, binomial probability test
Microbiologic findings in 162 patients with peritonsillar abscess and complications
| Organisms | PPA n = 36 | LS n = 26 | NF n = 33 | DM n = 46 | Other n = 21 | All n = 162 |
|---|---|---|---|---|---|---|
| Aerobic bacteria | ||||||
| Streptococcus | ||||||
| Group A | 9 | 6 | 1 | 4 | 20 | |
| Group C | 2 | 3 | 2 | 7 | ||
| Beta-hemolytic | 1 | 1 | 2 | 5 | ||
| Viridans group | 10 | 2 | 10 | 15 | 4 | 41 |
| spp. | 1 | 2 | 8 | 11 | ||
| | 2 | 1 | 3 | |||
| | 1 | 2 | 1 | 14 | 18 | |
| Coagulase-negative | 1 | 6 | 6 | 1 | 14 | |
| spp. | 4 | 4 | ||||
| | 1 | 1 | 2 | 4 | ||
| | 6 | 4 | 2 | 12 | ||
| | 1 | 1 | 6 | 8 | ||
| | 1 | 1 | ||||
| S | 1 | 1 | ||||
| | 1 | 1 | 2 | |||
| | 1 | 1 | ||||
| | 1 | 1 | ||||
| | 1 | 1 | ||||
| | 2 | 2 | ||||
| | 1 | 1 | ||||
| Anaerobic bacteria | ||||||
| | 1 | 4 | 9 | 14 | ||
| | 2 | 2 | ||||
| | 1 | 2 | 6 | 5 | 3 | 17 |
| | ||||||
| | 2 | 1 | 1 | 4 | ||
| | 3 | 15 | 1 | 2 | 21 | |
| spp. | 1 | 1 | ||||
| | 1 | 5 | 4 | 10 | ||
| | 1 | 1 | 1 | 3 | ||
| | 1 | 1 | ||||
| G + , non-spore-forming bacilli | 2 | 3 | 5 | |||
| Unspecified anaerobes | 9 | 2 | 4 | 1 | 16 | |
| Unspecified bacteria | 3 | 7 | 10 | |||
| Fungi | ||||||
| | 1 | 3 | 2 | 6 | ||
| | 1 | 1 | ||||
| Polymicrobial | ½ | 4/26 | 18/33 | 33/46 | 5/21 | 61/128 |
Bacterial names are reported in contemporary nomenclature (in contrast to Tables 4 and 5)
The names of the following bacteria are merged
Viridans group streptococci: viridans group (n = 16), Group F (n = 1), non-hemolytic (n = 4), mitis group (n = 2), sanguis (n = 1), salivarius (n = 2), intermedius (n = 1), constellatus (n = 3), anginosus group (n = 4), and milleri group (n = 7)
Enterococcus spp.: E. faecalis (n = 1) and Enterococcus species (n = 2)
Coagulase-negative staphylococci: hominis (n = 1), epidermidis (n = 6), haemolyticus (n = 2), and coagulase-negative staphylococci (n = 5)
Haemophilus spp.: Haemophilus influenza (n = 3) and Haemophilus parainfluenzae (n = 1)
Enterobacterales: Escherichia coli (n = 2), Enterobacter cloacae (n = 3), Enterobacter species (n = 1), Klebsiella pneumoniae (n = 2), Klebsiella species (n = 1), Proteus mirabilis (n = 1), Serratia marcescens (n = 1), and Citrobacter diversus (n = 1)
Bacteroides spp.: fragilis (n = 8), and species (n = 6)
Prevotella spp.: intermedia (n = 1), buccae (n = 1), oralis (n = 3), corporis (n = 1), melaninogenica (n = 6), and species (n = 5)
Peptostreptococcus spp.: Peptostreptococcus anaerobius (n = 3) and Peptostreptococcus species (n = 7)
G + , non-spore-forming bacilli: Eggerthella lenta (n = 2), Eubacterium species (n = 1), Bifidobacterium dentium (n = 1), and Eggerthia catenaformis (n = 1)
Unspecified: Gram-negative rod (n = 4), Gram-negative (n = 1), Gram-positive coccus (n = 2), Gram-positive rod (n = 1), Gram-positive (n = 2)
PPA parapharyngeal abscess, LS Lemierre´s syndrome, NF necrotizing fasciitis, DM descending mediastinitis, Spp species (no further specification was provided in the study), G- Gram-negative, G + Gram-positive, Arcano Arcanobacterium
Fig. 2Diagram of the prevalent findings in 162 patients with peritonsillar abscess and complications
Characteristics of 34 well-described patients with peritonsillar abscess (PTA) and necrotizing fasciitis (NF)
| References | Age (years) | Gender | Microbiologic findings | Treatment of PTA prior to NF development | Outcome | |
|---|---|---|---|---|---|---|
| Surgery | Antibiotics | |||||
| Wills [ | 35 | M | Spon perf | Iv. pen | Survived | |
| Wenig [ | 50 | M | AHS; | Simultaneousa | Died | |
| Wenig [ | 50 | M | AHS; | Incision | Iv. cefazolin | Died |
| Pedersen [ | 67 | M | No cultures | Simultaneousa | Died | |
| Lalwani [ | 33 | M | GCS; | Incision | Im. pen | Survived |
| Tovi [ | 20 | M | NIb | Died | ||
| Scott [ | 51 | M | Milleri group strep; NHS; anaerobes | Drainage | Iv. cefo, fluclo, metro | Survived |
| Maisel [ | 29 | M | VGS | NIb | Survived | |
| Jackson [ | 63 | M | Drainage | None | Survived | |
| Greinwald [ | 65 | M | GAS; | Incision | Iv. ampicillin | Survived |
| Hadfield [ | 53 | M | GCS; | Incision | Iv. cefo, metro | Survived |
| Skitalic [ | 50 | F | Simultaneousa | Survived | ||
| Djupesland [ | 39 | M | GAS | Simultaneousa | Died | |
| Djupesland [ | 36 | M | Milleri group strep.; | Asp | Iv. pen, tobra, metro | Survived |
| Nielsen [ | NI | NI | GCS | NIb | Died | |
| Safak [ | 43 | F | GAS; CNS; | Drainage | Iv. pen, im. chlor | Survived |
| Goldenberg [ | 53 | F | BHS | Incision | Iv. pen → pip-tazo | Survived |
| Vaid [ | 55 | M | GAS | Simultaneousa | Survived | |
| Beninsegna [ | 58 | M | Acute tons | Iv. ampicillin, metro | Survived | |
| Beninsegna [ | 80 | M | GAS; | Incision | Iv. ampicillin, metro | Survived |
| Losanoff [ | 54 | M | NHS; | No | Iv. ceftriaxo-ne, amoxicillin | Survived |
| Bono [ | 60 | M | No cultures | Spon perf | Iv. ceftriaxo-rine, metro | Died |
| Wolf [ | 62 | M | GAS | NIb | Survived | |
| Wolf [ | 49 | M | NHS | NIb | Survived | |
| Andres [ | 87 | F | NIb | Survived | ||
| Andres [ | 64 | F | NIb | Survived | ||
| Andres [ | 44 | M | NIb | Survived | ||
| Andres [ | 44 | M | NIb | Survived | ||
| Horváth [ | 55 | M | No bacterial growth | NIb | Survived | |
| Horváth [ | 61 | F | NIb | Survived | ||
| Flores [ | 38 | M | Simultaneousa | Survived | ||
| Brown [ | 56 | M | Incision | Clindamycin | Survived | |
| Irani [ | 33 | M | Incision | Iv. antibiotics | Survived | |
| Burstin [ | 47 | F | Milleri group strep.; anaerobes | No | Iv. antibiotics | Survived |
Bacterial names are written as reported by author (and not changed according to current nomenclature)
VGS viridans group streptococci, Spon perf spontaneous perforation, Pen penicillin, Iv Intravenous, Strep streptococci, Im intramuscular, Cefo cefotaxime, Fuclo flucloxacillin, AHS alpha-hemolytic streptococci, GCS Group C streptococci, NHS non-hemolytic streptococci, CNS coagulase-negative staphylococci, BHS beta-hemolytic streptococci, GAS Group A streptococci, Asp aspiration, Tobra tobramycin, Chlor chloramphenicol, Pip-tazo piperacillin-tazobactam, Tons tonsillectomy
aSimultaneous diagnosis and treatment of PTA and NF
bNo information regarding the time relation between PTA and NF
Characteristics of 44 well-described patients with peritonsillar abscess (PTA) and descending mediastinitis (DM)
| References | Age (years) | Gender | Microbiologic findings | Treatment of PTA prior to DM development | Outcome | |
|---|---|---|---|---|---|---|
| Surgery | Antibiotics | |||||
| Zgheib [ | 52 | M | Group A streptococci, | Drain | Ery → Clinda | Survived |
| Civen [ | 45 | M | Simultaneousa | Survived | ||
| Alsoub [ | 32 | M | VGS | Incision | Cephalothin | Survived |
| Alsoub [ | 47 | M | Negative cultures | Incision | Cephalothin | Survived |
| Cordero [ | 27 | M | Incision | None | Survived | |
| Nielsen [ | 25 | M | Acute tons | Iv. pen + metro | Survived | |
| Endo [ | 67 | M | Simultaneousa | Survived | ||
| Endo [ | 63 | F | Gram-positive coccus + Gram-positive rod + Gram-negative rod | Simultaneousa | Survived | |
| Manecke [ | 29 | M | Beta-hemolytic streptococci, | Simultaneousa | Survived | |
| Corsten [ | 71 | M | Gram-positive bacilli | No | Clinda | Survived |
| Sancho [ | 19 | F | NIb | Survived | ||
| Sancho [ | 71 | M | NIb | Died | ||
| Sancho [ | 39 | M | NIb | Survived | ||
| Laxmipathi [ | 70 | M | Drain | NI | Survived | |
| Asrar [ | 36 | M | Non-hemolytic streptococci | Incision | Iv. Unspec | Survived |
| Lautermann [ | 52 | NI | AHS, CNS | Simultaneousa | Survived | |
| Lautermann [ | 61 | NI | Negative cultures | Simultaneousa | Survived | |
| Mihos [ | 26 | M | Drain | Unspec | Survived | |
| Collin [ | 48 | M | Incision | Amox-clav + metro | Survived | |
| Sandner [ | 26 | M | AHS | Simultaneous1 | Survived | |
| Sandner [ | 45 | M | AHS, VGS, | Drain | Unspec | Died |
| Roccia [ | 65 | M | NIb | Survived | ||
| Roccia [ | 50 | M | NIb | Died | ||
| Roccia [ | 53 | M | Negative cultures | NIb | Died | |
| Roccia [ | 20 | M | NIb | Survived | ||
| Roccia [ | 37 | F | NIb | Survived | ||
| Roccia [ | 16 | F | NIb | Survived | ||
| Roccia [ | 58 | M | NIb | Survived | ||
| Roccia [ | 52 | M | VGS, | NIb | Died | |
| Roccia [ | 33 | F | NIb | Survived | ||
| Roccia [ | 65 | M | NIb | Survived | ||
| Roccia [ | 66 | M | NIb | Survived | ||
| Roccia [ | 57 | M | NIb | Died | ||
| Roccia [ | 58 | F | NIb | Survived | ||
| Roccia [ | 53 | M | VGS, | NIb | Survived | |
| Kinzer [ | 67 | NI | Simultaneousa | Died | ||
| De Freitas [ | 18 | F | NI | Simultaneousa | Survived | |
| De Freitas [ | 30 | F | NI | Incision | Unspec | Survived |
| Nakamura [ | 77 | F | Simultaneousa | Survived | ||
| Anderson [ | NI | F | VGS | Simultaneousa | Survived | |
| Iyer [ | 74 | M | Gram-positive, Gram-negative, anaerobes | Simultaneousa | Survived | |
| Gallo [ | 57 | M | NIb | Survived | ||
| Wahab [ | 29 | F | Negative cultures | Asp | Pen + metro → clari + metro | Survived |
| Geerts [ | 34 | M | Simultaneousa | Survived | ||
Bacterial names are written as reported by author (and not changed according to current nomenclature)
M male, F female, Drain drainage, Ery erythromycin, → changed to, Clinda clindamycin, VGS Viridans group streptococci, CNS Coagulase-negative staphylococci, Tons tonsillectomy, Iv intraveneous, Pen penicillin, Metro metronidazole, NI no information, Unspec unspecified, AHS alpha-hemolytic streptococci, Amox-clav amoxicillin-clavulanate, MR Methicillin resistant, Asp: aspiration, Clari clarithromycin
aSimultaneous diagnosis and treatment of PTA and DM
bNo information regarding the time relation between PTA and DM
Characteristics of patients (n = 12) with peritonsillar abscess (PTA) and upper airway obstruction
| Males | 7 (58%) |
| Children (< 16 years) | 5 (42%) |
| Infectious mononucleosis | 2 (17%) |
| Duration of admission (mean days) | 6.1 |
| Site of obstruction | |
| Oropharynx | 10 (83%) |
| Hypopharynx/larynx | 2 (17%) |
| Airway management | |
| Intubation | 2 (17%) |
| Acute tracheotomy | 2 (17%) |
| Surgical treatment | |
| Acute tonsillectomy | 8 (67%) |
| Incision and drainage | 3 (25%) |
| Bacterial findings in PTA cultures (n = 7) | |
| Streptococcus Group A | 2 (29%) |
| Streptococcus Group C/G | 2 (29%) |
| Viridans group streptococci | 2 (29%) |
| | 1 (14%) |
Microbiological findings in 26 patients with peritonsillar abscess (PTA) and Lemierre´s syndrome
| Culture site | ||||
|---|---|---|---|---|
| Bacteria | PTA (n = 5) | Blood (n = 18) | Liver abscess (n = 1) | Unknown (n = 3) |
| Aerobes | ||||
| Alpha-hemolytic streptococci | 1 | |||
| Viridans group streptococci | 1 | 1 | ||
| | 1 | 1 | ||
| Coagulase-negative staphylococci | 1 | |||
| 1 | ||||
| | 1 | |||
| | 1 | |||
| Anaerobes | ||||
| | 1 | 14 | 1 | |
| | 1 | 1 | ||
| | 2 | |||
| | 1 | 1 | ||
| | 1 | |||
| | 1 | |||
| | 1 | |||
The names of the following bacteria are merged
Viridans group streptococci: milleri group (n = 1) and Streptococcus constellatus (n = 1)
Spp species